作者: Thomas Cuny , Anne Barlier , Richard Feelders , Georges Weryha , Leo J. Hofland
DOI: 10.1016/J.ANDO.2014.10.002
关键词: Prolactinoma 、 Pituitary neoplasm 、 Medicine 、 Acromegaly 、 Surgery 、 ACTH-Secreting Pituitary Adenoma 、 Cushing's disease 、 Radiation therapy 、 Adenoma 、 Somatostatin analog 、 Oncology 、 Internal medicine
摘要: Pituitary adenomas (PA) represent in the majority of cases, benign tumors whose treatment currently associate surgery, medical therapies and radiotherapy a multidisciplinary approach. While trans-sphenoidal surgery remains, except for prolactin-secreting adenomas, first-line PA, it can considerably be hampered by existence an invasive and/or aggressive tumor which are often requested. In this review, we extensively discuss, both at molecular clinical levels, used development different phenotypes pituitary adenomas.